Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
31,523,534
-
Total 13F shares
-
1,671,573
-
Share change
-
-72,171
-
Total reported value
-
$2,543,489
-
Put/Call ratio
-
85%
-
Price per share
-
$1.52
-
Number of holders
-
23
-
Value change
-
-$139,367
-
Number of buys
-
8
-
Number of sells
-
6
Institutional Holders of ImmunoPrecise Antibodies Ltd. - Common Shares, no par value (IPA) as of Q1 2024
As of 31 Mar 2024,
ImmunoPrecise Antibodies Ltd. - Common Shares, no par value (IPA) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,671,573 shares.
The largest 10 holders included
INGALLS & SNYDER LLC, NORTHERN TRUST CORP, BANK OF MONTREAL /CAN/, CIBC WORLD MARKET INC., RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Gradient Capital Advisors, LLC, TWO SIGMA SECURITIES, LLC, Federation des caisses Desjardins du Quebec, and Royal Bank of Canada.
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.